Prices delayed by at least 15 minutes | Print
Galectin Therapeutics (GALT)
Common SharesThis share can be held in a Dealing accountISALifetime ISAJISASIPP
Company profile
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
Address
4960 Peachtree Industrial Boulevard
Suite 240
Norcross
GA
USA
30071
Telephone
+1 678 6203186
Forecast key dates
Name | Key Date |
---|---|
Galectin Therapeutics Inc Fourth Quarter Earnings Results for 2024 | 2025-03-28T00:00:00 |
Galectin Therapeutics Inc Annual Report for 2024 | 2025-03-28T00:00:00 |
Galectin Therapeutics Inc Annual General Meeting for 2024 | 2024-12-06T11:00:00 |
Galectin Therapeutics Inc Third Quarter Earnings Results for 2024 | 2024-11-13T00:00:00 |
Galectin Therapeutics Inc Second Quarter Earnings Results for 2024 | 2024-08-14T00:00:00 |
Galectin Therapeutics Inc First Quarter Earnings Results for 2024 | 2024-05-15T00:00:00 |
Previous key dates
Name | Key Date |
---|---|
Galectin Therapeutics Inc First Quarter Earnings Results for 2024 | 2024-05-15T00:00:00 |
Galectin Therapeutics Inc Fourth Quarter Earnings Results for 2023 | 2024-03-29T00:00:00 |
Galectin Therapeutics Inc Annual Report for 2023 | 2024-03-29T00:00:00 |
Galectin Therapeutics Inc Annual General Meeting for 2023 | 2023-12-07T11:00:00 |
Galectin Therapeutics Inc Third Quarter Earnings Results for 2023 | 2023-11-13T00:00:00 |
Galectin Therapeutics Inc Second Quarter Earnings Results for 2023 | 2023-08-14T00:00:00 |
Galectin Therapeutics Inc First Quarter Earnings Results for 2023 | 2023-05-15T00:00:00 |
H.C. Wainwright BioConnect Investment Conference | 2023-05-02T10:30:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.